Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Nuvation Bio has raised $250.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in June 2026.
Nuvation Bio's investors include Wellington Management, Redmile Group, Perceptive Advisors, OrbiMed, Fidelity.
Nuvation Bio is headquartered in New York, United States.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Nuvation Bio is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nuvation Bio — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/nuvation-bio. Accessed September 25, 2026.
VCBacked. (2026). Nuvation Bio — Funding & Investors. Retrieved September 25, 2026, from https://www.vcbacked.co/company/nuvation-bio
{{cite web |title=Nuvation Bio — Funding & Investors |url=https://www.vcbacked.co/company/nuvation-bio |website=VCBacked |access-date=September 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated